Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mehmuda Hussain
Observed names:
M. Hussain,
Maha Hussain
Institution:
KLE Academy of Higher Education and Research
Observed institutions:
Northwestern University,
Jawaharlal Nehru Medical College,
KLE Academy of Higher Education and Research,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
ORCID:
0009-0005-3375-8736
Observed ORCID:
0009-0005-3375-8736
OpenAlex ID:
A5023262249
Functionalized Nanoscaffolds for Drug Delivery Using Biomaterials: A Glimmer of Hope in Diabetic Wound Management
2025
·
Melvin Vincent Dsouza
, Suneel Dodamani
, et al.
·
Regenerative Engineering and Translational Medicine
·
4
1784P Prostate-specific antigen (PSA) outcomes with darolutamide (DARO): Androgen-deprivation therapy (ADT) and docetaxel (DOC) in patients (pts) with high- and low-volume metastatic hormone-sensitive prostate cancer (mHSPC) in ARASENS
2023
·
F. Saad
, M. Hussain
, et al.
·
Annals of Oncology
·
3
PDF
Assessing the role of the microbiome in the pathogenesis of prostate cancer and its relationship with patient clinical characteristics
2025
·
Mehmuda Hussain
, Rajendra Nerli
, et al.
·
Proceedings of the Indian National Science Academy
·
1
255O Darolutamide (DARO) in combination with androgen-deprivation therapy (ADT) and docetaxel (DOC) in Chinese patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) in the phase III ARASENS study
2023
·
S. Wang
, C. Fu
, et al.
·
Annals of Oncology
·
1
PDF
Efficacy and safety of darolutamide (DARO) in combination with androgen-deprivation therapy (ADT) and docetaxel (DOC) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC) by metastatic burden: Subgroup analyses of ARASENS
2023
·
B. Tombal
, F. Saad
, et al.
·
European Urology
·
1
173P Clinical outcomes in stratification subgroups in the ARASENS study in metastatic hormone-sensitive prostate cancer (mHSPC)
2022
·
F. Parnis
, B. Tombal
, et al.
·
Annals of Oncology
·
1
Interventional Radiology Techniques for Managing Obstetric Haemorrhage and Gynaecological Conditions: An Eight-Year Analysis
2026
·
Hema Patil
, Navin Mulimani
, et al.
·
The Journal of Obstetrics and Gynecology of India
Next-generation sequencing-based analysis of prostate tissue microbiome in prostate cancer patients: a hospital-based study
2025
·
Mehmuda Hussain
, Rajendra Nerli
, et al.
·
Molecular Biology Reports
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial
2024
·
Bertrand Tombal
, Maha Hussain
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
9
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type